Memorial Sloan Kettering Cancer Center

https://www.mskcc.org/healthcare-professionals

Refer a Patient to MSKCC: mskcc.org/refer

 

Memorial Sloan Kettering Cancer Center
A

2021 ASCO Highlights on 1L Treatment for Advanced Melanoma: RELATIVITY-047 Phase III Study of Relatlimab + Nivolumab vs. Nivolumab Alone

By Memorial Sloan Kettering Cancer Center FEATURING Allison Betof Warner
By Memorial Sloan Kettering Cancer Center FEATURING Allison Betof Warner
50 views
July 12, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri

Featured Video

05:15
Lilly Medical Affairs

Unmet Needs for Patients With HR+, HER2- Early Breast Cancer at a Hi…

Feat. H. Rugo
Skin
29:16

IGCS 2023 Insights: "Vulvovaginal Melanoma - Current Approaches & Em…

Insights from 2023 IGCS Annual Meeting

M. Leitao

49 views
24:53

Recent Melanoma Updates

OncoAlert

A. Betof Warner

395 views
04:04

Clinical Trials in Melanoma

GRACE

M. Postow

56 views
02:49

Major Advances in Uveal Melanoma

GRACE

M. Postow

513 views
04:28

BRAF Mutated Melanoma

GRACE

M. Postow

301 views
03:10

Side Effects of Immunotherapy in Melanoma

GRACE

M. Postow

27 views
08:00

Immunotherapy in Treatment of Melanoma

GRACE

M. Postow

148 views
05:50

Melanoma and Current Treatment Options

GRACE

M. Postow

231 views
11:42

Who Should Be Getting Adjuvant Therapy in Melanoma?

Memorial Sloan Kettering Cancer Center

A. Betof Warner

422 views
47:34

Confronting Inequity in Modern Therapy for Rare Melanomas

Massachusetts General Hospital Cancer Center

A. Shoushtari

75 views
10:11

2022 Updates in the Treatment of Melanoma

Memorial Sloan Kettering Cancer Center

M. Postow

930 views
06:32

2021 ASCO Highlights on 1L Treatment for Advanced Melanoma: RELATIVI…

Memorial Sloan Kettering Cancer Center

A. Betof Warner

50 views
15:05

2020 Updates on Stage 4 Melanoma: Do BRAF+ MEK Combos Improve PFS? I…

Memorial Sloan Kettering Cancer Center

A. Betof Warner

301 views
13:02

Skin Toxicities are First and Frequent in Immunotherapy

2019 MASCC/ISOO Annual Meeting on Supportive Care in Cancer

M. Lacouture

128 views
14:10

Systemic Therapy for Melanoma Brain Metastases: RAF/MEK Inhibitors a…

Weill Cornell Medicine Courses and Meetings

P. Chapman

89 views